April 9, 2018 / 5:26 AM / 14 days ago

BRIEF-Menlo Therapeutics Announces Results From Phase 2 Trial Of Serlopitant For Pruritus Associated With Atopic Dermatitis

April 9 (Reuters) - Menlo Therapeutics Inc:

* MENLO THERAPEUTICS ANNOUNCES RESULTS FROM A PHASE 2 TRIAL OF SERLOPITANT FOR PRURITUS ASSOCIATED WITH ATOPIC DERMATITIS

* ‍STUDY DID NOT MEET ITS PRIMARY OR KEY SECONDARY EFFICACY ENDPOINTS

* ‍SERLOPITANT WAS WELL-TOLERATED IN THIS STUDY​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below